NCT03361540View on ClinicalTrials.gov

ASP8302 Single and Multiple Ascending Oral Dose Study in Non-elderly Healthy Japanese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

November 14, 2017

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Healthy Subjects
Interventions
DRUG

ASP8302

ASP8302 will be administered orally.

DRUG

Placebo

Placebo will be administered orally.

Trial Locations (1)

Unknown

Site JP00001, Toshima City

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY